Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Racial disparities in the use of palliative therapy for ureteral obstruction among elderly patients with advanced prostate cancer.

Spencer BA, Insel BJ, Hershman DL, Benson MC, Neugut AI.

Support Care Cancer. 2013 May;21(5):1303-11. doi: 10.1007/s00520-012-1666-6. Epub 2013 Jan 6.

PMID:
23292697
3.

Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.

Schmid M, Meyer CP, Reznor G, Choueiri TK, Hanske J, Sammon JD, Abdollah F, Chun FK, Kibel AS, Tucker-Seeley RD, Kantoff PW, Lipsitz SR, Menon M, Nguyen PL, Trinh QD.

JAMA Oncol. 2016 Jan;2(1):85-93. doi: 10.1001/jamaoncol.2015.3384.

4.

Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies.

Song Y, Fei X, Song Y.

Int J Gynecol Cancer. 2012 May;22(4):697-702. doi: 10.1097/IGC.0b013e318243b475.

PMID:
22315095
5.

Nephrostomy insertion for patients with bilateral ureteric obstruction caused by prostate cancer.

Nariculam J, Murphy DG, Jenner C, Sellars N, Gwyther S, Gordon SG, Swinn MJ.

Br J Radiol. 2009 Jul;82(979):571-6. doi: 10.1259/bjr/38306763. Epub 2009 Jan 19.

PMID:
19153185
6.

Percutaneous transrenal ureteroneocystostomy.

Rosdy E.

J Endourol. 1999 Jun;13(5):369-72.

PMID:
10446799
7.

The management of malignant ureteral obstruction treated with ureteral stents.

Ganatra AM, Loughlin KR.

J Urol. 2005 Dec;174(6):2125-8.

PMID:
16280741
8.

Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults.

Mack CD, Carpenter W, Meyer AM, Sanoff H, Stürmer T.

Cancer. 2012 Jun 1;118(11):2925-34. doi: 10.1002/cncr.26622. Epub 2011 Nov 9.

9.

The role of percutaneous nephrostomy in malignant ureteric obstruction.

Wilson JR, Urwin GH, Stower MJ.

Ann R Coll Surg Engl. 2005 Jan;87(1):21-4.

10.

[Relief of upper urinary tract obstruction in patients with cancer of the prostate].

Kraemer PC, Borre M.

Ugeskr Laeger. 2009 Mar 9;171(11):873-6. Danish.

PMID:
19278608
11.

Racial Disparities in End-of-Life Care Among Patients With Prostate Cancer: A Population-Based Study.

Abdollah F, Sammon JD, Majumder K, Reznor G, Gandaglia G, Sood A, Hevelone N, Kibel AS, Nguyen PL, Choueiri TK, Selvaggi KJ, Menon M, Trinh QD.

J Natl Compr Canc Netw. 2015 Sep;13(9):1131-8.

PMID:
26358797
12.

Wire-reinforced ureteral stents to rescue from nephrostomy tube in extrinsic ureteral obstruction.

Dauw CA, Faerber GJ, Hollingsworth JM 3rd, Wolf JS Jr.

Can J Urol. 2015 Jun;22(3):7806-10.

PMID:
26068630
13.

Health disparities in staging of SEER-medicare prostate cancer patients in the United States.

Mullins CD, Onukwugha E, Bikov K, Seal B, Hussain A.

Urology. 2010 Sep;76(3):566-72. doi: 10.1016/j.urology.2009.10.061. Epub 2010 Feb 16.

14.

Income inequality and treatment of African American men with high-risk prostate cancer.

Ziehr DR, Mahal BA, Aizer AA, Hyatt AS, Beard CJ, D Amico AV, Choueiri TK, Elfiky A, Lathan CS, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL.

Urol Oncol. 2015 Jan;33(1):18.e7-18.e13. doi: 10.1016/j.urolonc.2014.09.005. Epub 2014 Oct 11.

PMID:
25306287
15.

Racial disparities in the treatment of advanced epithelial ovarian cancer.

Howell EA, Egorova N, Hayes MP, Wisnivesky J, Franco R, Bickell N.

Obstet Gynecol. 2013 Nov;122(5):1025-32. doi: 10.1097/AOG.0b013e3182a92011.

16.

Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study.

ElSheemy MS, Shouman AM, Shoukry AI, ElShenoufy A, Aboulela W, Daw K, Hussein AA, Morsi HA, Badawy H.

BJU Int. 2015 Mar;115(3):473-9. doi: 10.1111/bju.12768. Epub 2014 Oct 20.

17.

Role of percutaneous nephrostomy (PCN) in malignant ureteral obstruction.

Jalbani MH, Deenari RA, Dholia KR, Oad AK, Arbani IA.

J Pak Med Assoc. 2010 Apr;60(4):280-3.

18.

Ureteral obstruction associated with prostate cancer: the outcome after ultrasonographic percutaneous nephrostomy.

Bordinazzo R, Benecchi L, Cazzaniga A, Vercesi A, Privitera O.

Arch Ital Urol Androl. 1994 Sep;66(4 Suppl):101-6.

PMID:
7889041
19.

Racial disparities in treatment and survival of male breast cancer.

Crew KD, Neugut AI, Wang X, Jacobson JS, Grann VR, Raptis G, Hershman DL.

J Clin Oncol. 2007 Mar 20;25(9):1089-98.

PMID:
17369572
20.

Residual treatment disparities after oncology referral for rectal cancer.

Morris AM, Billingsley KG, Hayanga AJ, Matthews B, Baldwin LM, Birkmeyer JD.

J Natl Cancer Inst. 2008 May 21;100(10):738-44. doi: 10.1093/jnci/djn145. Epub 2008 May 13.

Supplemental Content

Support Center